Literature DB >> 20018620

Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.

Laureen S Ojalvo1, Charles A Whittaker, John S Condeelis, Jeffrey W Pollard.   

Abstract

The tumor microenvironment modifies the malignancy of tumors. In solid tumors, this environment is populated by many macrophages that, in genetic studies that depleted these cells from mouse models of breast cancer, were shown to promote tumor progression to malignancy and increase metastatic potential. Mechanistic studies showed that these tumor-promoting effects of macrophages are through the stimulation of tumor cell migration, invasion, intravasation, and enhancement of angiogenesis. Using an in vivo invasion assay, it was demonstrated that invasive carcinoma cells are a unique subpopulation of tumor cells whose invasion and chemotaxis is dependent on the comigration of tumor-associated macrophages (TAMs) with obligate reciprocal signaling through an epidermal growth factor-CSF-1 paracrine loop. In this study, these invasion-promoting macrophages were isolated and subjected to analysis of their transcriptome in comparison with TAMs isolated indiscriminately to function using established macrophage markers. Unsupervised analysis of transcript patterns showed that the invasion-associated TAMs represent a unique subpopulation of TAMs that, by gene ontology criteria, have gene expression patterns related to tissue and organ development. Gene set enrichment analysis showed that these macrophages are also specifically enriched for molecules involved in Wnt-signaling. Previously, it was shown that macrophage-derived Wnt molecules promote vascular remodeling and that tumor cells are highly motile and intravasate around perivascular TAM clusters. Taken together, we conjecture that invasive TAMs link angiogenesis and tumor invasion and that Wnt-signaling plays a role in mediating their activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018620      PMCID: PMC3226722          DOI: 10.4049/jimmunol.0902360

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

2.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering.

Authors:  Ryota Suzuki; Hidetoshi Shimodaira
Journal:  Bioinformatics       Date:  2006-04-04       Impact factor: 6.937

3.  Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland.

Authors:  Wendy V Ingman; Jeff Wyckoff; Valerie Gouon-Evans; John Condeelis; Jeffrey W Pollard
Journal:  Dev Dyn       Date:  2006-12       Impact factor: 3.780

4.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

Authors:  Daniel R Rhodes; Shanker Kalyana-Sundaram; Vasudeva Mahavisno; Radhika Varambally; Jianjun Yu; Benjamin B Briggs; Terrence R Barrette; Matthew J Anstet; Colleen Kincead-Beal; Prakash Kulkarni; Sooryanaryana Varambally; Debashis Ghosh; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

5.  Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.

Authors:  Olga Vasiljeva; Anna Papazoglou; Achim Krüger; Harald Brodoefel; Matvey Korovin; Jan Deussing; Nicole Augustin; Boye S Nielsen; Kasper Almholt; Matthew Bogyo; Christoph Peters; Thomas Reinheckel
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

6.  Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

Authors:  Anna V Ivshina; Joshy George; Oleg Senko; Benjamin Mow; Thomas C Putti; Johanna Smeds; Thomas Lindahl; Yudi Pawitan; Per Hall; Hans Nordgren; John E L Wong; Edison T Liu; Jonas Bergh; Vladimir A Kuznetsov; Lance D Miller
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.

Authors:  Jeffrey B Wyckoff; Yarong Wang; Elaine Y Lin; Jiu-feng Li; Sumanta Goswami; E Richard Stanley; Jeffrey E Segall; Jeffrey W Pollard; John Condeelis
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

8.  Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors.

Authors:  Weigang Wang; Jeffrey B Wyckoff; Sumanta Goswami; Yarong Wang; Mazen Sidani; Jeffrey E Segall; John S Condeelis
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

9.  Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines.

Authors:  T Pukrop; F Klemm; Th Hagemann; D Gradl; M Schulz; S Siemes; L Trümper; C Binder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-28       Impact factor: 11.205

10.  The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors.

Authors:  Weigang Wang; Ghassan Mouneimne; Mazen Sidani; Jeffrey Wyckoff; Xiaoming Chen; Anastasia Makris; Sumanta Goswami; Anne R Bresnick; John S Condeelis
Journal:  J Cell Biol       Date:  2006-05-01       Impact factor: 10.539

View more
  95 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 3.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

4.  Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression.

Authors:  Xuezheng Sun; Patricia Casbas-Hernandez; Carol Bigelow; Liza Makowski; D Joseph Jerry; Sallie Smith Schneider; Melissa A Troester
Journal:  Breast Cancer Res Treat       Date:  2011-10-15       Impact factor: 4.872

5.  Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.

Authors:  Delisha A Stewart; Yinmeng Yang; Liza Makowski; Melissa A Troester
Journal:  Mol Cancer Res       Date:  2012-04-24       Impact factor: 5.852

Review 6.  Macrophages: The Road Less Traveled, Changing Anticancer Therapy.

Authors:  Jennifer L Guerriero
Journal:  Trends Mol Med       Date:  2018-04-11       Impact factor: 11.951

Review 7.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

8.  Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis.

Authors:  Crystal Morales; Saleh Rachidi; Feng Hong; Shaoli Sun; Xinshou Ouyang; Caroline Wallace; Yongliang Zhang; Elizabeth Garret-Mayer; Jennifer Wu; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

9.  The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells.

Authors:  Kutlu G Elpek; Viviana Cremasco; Hua Shen; Christopher J Harvey; Kai W Wucherpfennig; Daniel R Goldstein; Paul A Monach; Shannon J Turley
Journal:  Cancer Immunol Res       Date:  2014-03-31       Impact factor: 11.151

10.  Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions.

Authors:  Lido Calorini; Francesca Bianchini
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.